These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 9724903)
1. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. Ramchandani M; Robinson D J Control Release; 1998 Jul; 54(2):167-75. PubMed ID: 9724903 [TBL] [Abstract][Full Text] [Related]
2. Development of an in vitro dissolution method using microdialysis sampling technique for implantable drug delivery systems. Dash AK; Haney PW; Garavalia MJ J Pharm Sci; 1999 Oct; 88(10):1036-40. PubMed ID: 10514352 [TBL] [Abstract][Full Text] [Related]
3. The design of flexible ciprofloxacin-loaded PLGA implants using a reversed phase separation/coacervation method. Park PI; Makoid M; Jonnalagadda S Eur J Pharm Biopharm; 2011 Feb; 77(2):233-9. PubMed ID: 21145965 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections. Benoit MA; Mousset B; Delloye C; Bouillet R; Gillard J Int Orthop; 1997; 21(6):403-8. PubMed ID: 9498152 [TBL] [Abstract][Full Text] [Related]
5. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant. Koort JK; Makinen TJ; Suokas E; Veiranto M; Jalava J; Tormala P; Aro HT Acta Orthop; 2008 Apr; 79(2):295-301. PubMed ID: 18484258 [TBL] [Abstract][Full Text] [Related]
6. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor. Desai KG; Mallery SR; Schwendeman SP Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553 [TBL] [Abstract][Full Text] [Related]
7. Bioabsorbable ciprofloxacin-containing and plain self-reinforced polylactide-polyglycolide 80/20 screws: pullout strength properties in human cadaver parietal bones. Tiainen J; Veiranto M; Suokas E; Törmälä P; Waris T; Ninkovic M; Ashammakhi N J Craniofac Surg; 2002 May; 13(3):427-33. PubMed ID: 12040214 [TBL] [Abstract][Full Text] [Related]
8. Gatifloxacine-loaded PLGA and β-tricalcium phosphate composite for treating osteomyelitis. Tamazawa G; Ito A; Miyai T; Matsuno T; Kitahara K; Sogo Y; Kimishima K; Satoh T Dent Mater J; 2011; 30(3):264-73. PubMed ID: 21597226 [TBL] [Abstract][Full Text] [Related]
9. Gatifloxacin biodegradable implant for treatment of experimental osteomyelitis: in vitro and in vivo evaluation. El-Kamel AH; Baddour MM Drug Deliv; 2007 Aug; 14(6):349-56. PubMed ID: 17701524 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: Part II. Biodegradation and drug delivery application. Wang N; Wu XS J Biomater Sci Polym Ed; 1997; 9(1):75-87. PubMed ID: 9505204 [TBL] [Abstract][Full Text] [Related]
11. Rheological properties of PLGA film-based implants: correlation with polymer degradation and SPf66 antimalaric synthetic peptide release. Santoveña A; Alvarez-Lorenzo C; Concheiro A; Llabrés M; Fariña JB Biomaterials; 2004 Feb; 25(5):925-31. PubMed ID: 14609681 [TBL] [Abstract][Full Text] [Related]
13. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip. Grayson AC; Voskerician G; Lynn A; Anderson JM; Cima MJ; Langer R J Biomater Sci Polym Ed; 2004; 15(10):1281-304. PubMed ID: 15559850 [TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Ravi Kumar MN; Bakowsky U; Lehr CM Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) fibers. Crow BB; Borneman AF; Hawkins DL; Smith GM; Nelson KD Tissue Eng; 2005; 11(7-8):1077-84. PubMed ID: 16144443 [TBL] [Abstract][Full Text] [Related]
16. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Kim DH; Martin DC Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Woo BH; Fink BF; Page R; Schrier JA; Jo YW; Jiang G; DeLuca M; Vasconez HC; DeLuca PP Pharm Res; 2001 Dec; 18(12):1747-53. PubMed ID: 11785696 [TBL] [Abstract][Full Text] [Related]
18. Development of poly (lactic-co-glycolic acid) (PLGA) based implants using hot melt extrusion (HME) for sustained release of drugs: The impacts of PLGA's material characteristics. Yang F; Stahnke R; Lawal K; Mahnen C; Duffy P; Xu S; Durig T Int J Pharm; 2024 Sep; 663():124556. PubMed ID: 39122196 [TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer. Isobe M; Yamazaki Y; Oida S; Ishihara K; Nakabayashi N; Amagasa T J Biomed Mater Res; 1996 Nov; 32(3):433-8. PubMed ID: 8897149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]